Design, physico-chemical characterization andin vitrobiological activity of organogold(iii) glycoconjugates
- 19 May 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 50 (25) , 8963-8979
Abstract
To develop new metal-based glycoconjugates as potential anticancer agents, four organometallic gold(III)–dithiocarbamato glycoconjugates of the type [AuIII(2-Bnpy)(SSC-Inp-GlcN)](PF6) (2-Bnpy: 2-benzylpyridine; Inp: isonipecotic moiety; GlcN: amino-glucose scaffold; Au3–Au6) and the corresponding model non-glycosylated counterparts [AuIII(2-Bnpy)(SSC-Inp-R)](PF6) (R: OEt (Au1), NH2 (Au2)) have been generated and characterized by means of several analytical techniques (elemental analysis, FT-IR, 1H-/13C-NMR, ESI-MS, UV-Vis, X-ray crystallography). Their stability under physiologically-relevant conditions (PBS solution) and n-octanol/PBS distribution coefficient (D7.4) have also been evaluated. Gold(III) glycoconjugates showed an antiproliferative effect against ovarian carcinoma A2780 cells, with GI50 values in the low micromolar range. Remarkably, their cell growth inhibitory effect increases upon the addition of a glucose transporter 1 (GLUT1) inhibitor, thus ruling out the involvement of GLUT1 in their transport inside the cell. Additional mechanistic studies have been carried out in A2780 cells, supporting the hypothesis of a facilitated diffusion mechanism (possibly mediated by glucose transporters other than GLUT1), and revealing their capability to act as topoisomerase I and II inhibitors and to disrupt mitochondrial membrane integrity, leading to the generation of ROS, thus resulting in the promotion of oxidative stress and, eventually, cell death.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
- University of Galway (College of Science Scholarship 2014, Erasmus+Traineeship 2019, Millennium Fund Minor Project 2013)
- Irish Research Council (GOIPG/2015/2961, GOIPG/2017/1170)
This publication has 88 references indexed in Scilit:
- Cancer cell metabolism: implications for therapeutic targetsExperimental & Molecular Medicine, 2013
- Targeting cellular metabolism to improve cancer therapeuticsCell Death & Disease, 2013
- Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell deathCell Death & Disease, 2012
- Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast CancersPathology and Oncology Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The sites and topology of mitochondrial superoxide productionExperimental Gerontology, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- DNA topoisomerase II and its growing repertoire of biological functionsNature Reviews Cancer, 2009
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Targeted cancer therapyNature, 2004